News Summary:
Cogna reported robust growth in revenue, EBITDA, and free cash flow for 2025 on March 12, 2026, citing strong operational and financial performance across all segments. Strategic capital allocation reduced leverage, and successful integration of new business lines positioned the company for continued double-digit growth in 2026. This followed the company's Q4 net profit of 220 million reais, announced on March 10, 2026, which missed the IBES estimate of 334 million reais, alongside recurring EBITDA of 769 million reais. Previously, an earnings call transcript on November 7, 2025, detailed Cogna's strong Q3 2025 financial results, including 192 million reais in net profit and 423 million reais in recurring EBITDA. The company saw nearly 19% year-over-year revenue growth and a positive shift to profit from a previous loss, driven by increased student intake and program expansion. Despite these results, its stock declined 5.37% to 8.75 BRL due to investor concerns. Earlier, on August 8, 2025, Cogna acquired Faculdade de Medicina de Dourados for 54.4 million reais.
Subscribe for full access to Cogna's products in full detail 
